Conference on personalised cancer therapy

Barcelona: 3-4 December 2012

The organisers of the IDIBELL Cancer Conference (ICC) on Personalized Cancer Medicine – Manel Esteller, George Thomas, Cristina Muñoz- Pinedo and Sara Kozma – will present 21speakers for the event, all leading oncologists and cancer researchers, particularly those working in the study of genetic and epigenetic defects leading to the selection of cancer patients for new drug therapies. The meeting aims to highlight the latest understanding of biological mechanisms and natural history of cancer, thus providing novel targets for therapy, as well as to discuss the molecular mechanisms involved in the stratification of oncology patents according to the recently described molecular markers. Special focus: Epigenetics and DNA Repair and the metabolism and cell signalling areas with the updated clinical applications. Details: http://bocemtium.com

05.11.2012

News • Adverse effects of lung cancer treatment

Collateral damage: the thymus in NSCLC radiotherapy

Exposure of the thymus to radiation during lung cancer treatment is linked to an increased risk of the cancer spreading to other parts of the body and overall worse outcomes, a new study finds.

News • Promising trial results

Rectal cancer treatment spares surgery for most patients

Surgical treatment of rectal cancer often means complete removal of the rectum. Now, new trial results suggest a different approach that lets patients keep their rectum – along with significant…

News • Nanomedicine

Reshaping the gut microbiome to boost chemotherapy

A new study has identified a way to reshape the gut microbiome that can enhance the delivery of certain chemotherapies to tumors, making these nanoparticle-based cancer drugs more effective.

Related articles